Inhalers Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

Inhalers Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update


Summary

GlobalData's Medical Devices sector report, “Inhalers Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update provides comprehensive information about the Inhalers pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Inhaler devices deliver medication to the lungs.

Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Inhalers under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Inhalers and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Inhalers under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date


  • About GlobalData
  • Introduction
    • Inhalers Overview
  • Products under Development
    • Inhalers - Pipeline Products by Stage of Development
      • Table Inhalers - Pipeline Products by Stage of Development
      • Table Inhalers - Pipeline Products by Stage of Development
    • Inhalers - Pipeline Products by Segment
      • Table Inhalers - Pipeline Products by Segment
      • Table Inhalers - Pipeline Products by Segment
    • Inhalers - Pipeline Products by Territory
      • Table Inhalers - Pipeline Products by Territory
      • Table Inhalers - Pipeline Products by Territory
    • Inhalers - Pipeline Products by Regulatory Path
      • Table Inhalers - Pipeline Products by Regulatory Path
      • Table Inhalers - Pipeline Products by Regulatory Path
    • Inhalers - Pipeline Products by Estimated Approval Date
      • Table Inhalers - Pipeline Products by Estimated Approval Date
      • Table Inhalers - Pipeline Products by Estimated Approval Date
    • Inhalers - Ongoing Clinical Trials
      • Table Inhalers - Ongoing Clinical Trials
      • Table Inhalers - Ongoing Clinical Trials
  • Inhalers - Pipeline Products under Development by Companies
    • Inhalers Companies - Pipeline Products by Stage of Development
      • Table Inhalers Companies - Pipeline Products by Stage of Development
    • Inhalers - Pipeline Products by Stage of Development
      • Table Inhalers - Pipeline Products by Stage of Development
  • Inhalers Companies and Product Overview
    • 1nhaler Ltd Company Overview
      • 1nhaler Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table 1nhaler Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Single-Use Dry Powder Inhaler - Product Status
        • Table Single-Use Dry Powder Inhaler - Product Description
    • Acorda Therapeutics Inc Company Overview
      • Acorda Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Acorda Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table INBRIJA - Product Status
        • Table INBRIJA - Product Description
        • Table PLUMIAZ Nasal Spray Device - Product Status
        • Table PLUMIAZ Nasal Spray Device - Product Description
        • Table Acorda Therapeutics Inc - Ongoing Clinical Trials Overview
        • Table INBRIJA - Usability of Levodopa Cyclops Compared to INBRIJA During an Off Episode in Parkinson's Disease Patients
    • Advent Pharmaceuticals Pty Ltd Company Overview
      • Advent Pharmaceuticals Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Advent Pharmaceuticals Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table g60 Dry Powder Inhaler - Product Status
        • Table g60 Dry Powder Inhaler - Product Description
    • Aerami Therapeutics Holdings Inc Company Overview
      • Aerami Therapeutics Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Aerami Therapeutics Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table AFINA Smart Inhaler - Product Status
        • Table AFINA Smart Inhaler - Product Description
    • Aespira Ltd. Company Overview
      • Aespira Ltd. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Aespira Ltd. Pipeline Products & Ongoing Clinical Trials Overview
        • Table resQhaler - Product Status
        • Table resQhaler - Product Description
    • AKELA Pharma Inc. (Formerly LAB International, Inc.) (Inactive) Company Overview
      • AKELA Pharma Inc. (Formerly LAB International, Inc.) (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table AKELA Pharma Inc. (Formerly LAB International, Inc.) (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Fentanyl TAIFUN Inhaler - Product Status
        • Table Fentanyl TAIFUN Inhaler - Product Description
    • AsMedic Ltd. Company Overview
      • AsMedic Ltd. Pipeline Products & Ongoing Clinical Trials Overview
        • Table AsMedic Ltd. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Reusable Inhaler - Product Status
        • Table Reusable Inhaler - Product Description
    • Ayrton Saunders Ltd Company Overview
      • Ayrton Saunders Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Ayrton Saunders Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table VOKE 2.0 - Product Status
        • Table VOKE 2.0 - Product Description
    • Bayer AG Company Overview
      • Bayer AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table Bayer AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table Ciprofloxacin Dry Powder Inhaler - Product Status
        • Table Ciprofloxacin Dry Powder Inhaler - Product Description
        • Table Claricare - Product Status
        • Table Claricare - Product Description
    • Belhaven Biopharma Inc Company Overview
      • Belhaven Biopharma Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Belhaven Biopharma Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Nasdepi - Product Status
        • Table Nasdepi - Product Description
    • Bellerophon Therapeutics Inc Company Overview
      • Bellerophon Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Bellerophon Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Mark2 Device - Product Status
        • Table Mark2 Device - Product Description
    • Cambridge Healthcare Innovations Ltd Company Overview
      • Cambridge Healthcare Innovations Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Cambridge Healthcare Innovations Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table aeolus Dry-Powder Inhaler (DPI) - Product Status
        • Table aeolus Dry-Powder Inhaler (DPI) - Product Description
    • Cipla Ltd Company Overview
      • Cipla Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Cipla Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Complex Inhaler - Product Status
        • Table Complex Inhaler - Product Description
        • Table Smart Inhaler - Product Status
        • Table Smart Inhaler - Product Description
    • Covinhaler LLP Company Overview
      • Covinhaler LLP Pipeline Products & Ongoing Clinical Trials Overview
        • Table Covinhaler LLP Pipeline Products & Ongoing Clinical Trials Overview
        • Table Pocket Inhaler - COVID-19 - Product Status
        • Table Pocket Inhaler - COVID-19 - Product Description
    • Creare LLC Company Overview
      • Creare LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Creare LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Intranasal Dry Powder Inhaler - Product Status
        • Table Intranasal Dry Powder Inhaler - Product Description
    • De Motu Cordis Pty Ltd Company Overview
      • De Motu Cordis Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table De Motu Cordis Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table DMC Inhaler - Product Status
        • Table DMC Inhaler - Product Description
        • Table De Motu Cordis Pty Ltd - Ongoing Clinical Trials Overview
        • Table DMC Inhaler - A Phase 1, 2-Part Study in Healthy Male and Female Participants; Part 1 - A Randomised, Double-Blind, Placebo-Controlled, Single Ascending Dose-Escalation Study of Inhaled DMC-IH1; Part 2 - An Open-Label, 3-Arm Study Assessing the Carryover Effects of Inhaled (DMC-IH1) and Intramuscular (EpiPen) Epinephrine
    • DMK Pharmaceuticals Corp Company Overview
      • DMK Pharmaceuticals Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table DMK Pharmaceuticals Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table APC-4000 Fluticasone Dry Powder Inhaler - Product Status
        • Table APC-4000 Fluticasone Dry Powder Inhaler - Product Description
    • Drexel University Company Overview
      • Drexel University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Drexel University Pipeline Products & Ongoing Clinical Trials Overview
        • Table BREATHE Inhaler - Product Status
        • Table BREATHE Inhaler - Product Description
    • Engage Therapeutics Inc Company Overview
      • Engage Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Engage Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Staccato Alprazolam - Product Status
        • Table Staccato Alprazolam - Product Description
    • Findair Sp zoo Company Overview
      • Findair Sp zoo Pipeline Products & Ongoing Clinical Trials Overview
        • Table Findair Sp zoo Pipeline Products & Ongoing Clinical Trials Overview
        • Table FindAir ONE Smart Inhaler - Product Status
        • Table FindAir ONE Smart Inhaler - Product Description
        • Table Findair Sp zoo - Ongoing Clinical Trials Overview
        • Table FindAir ONE Smart Inhaler - Triple Therapy Convenience by the Use of One or Multiple Inhalers and Digital Support in Chronic Obstructive Pulmonary Disease
    • FocusStart LLC Company Overview
      • FocusStart LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table FocusStart LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Smart Inhaler - Product Status
        • Table Smart Inhaler - Product Description
    • Glenmark Pharmaceuticals Ltd Company Overview
      • Glenmark Pharmaceuticals Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Glenmark Pharmaceuticals Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Tiogiva - Product Status
        • Table Tiogiva - Product Description
    • GSK plc Company Overview
      • GSK plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table GSK plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Gemini Multi-Dose Combination Inhaler - Product Status
        • Table Gemini Multi-Dose Combination Inhaler - Product Description
    • Hovione Technology Ltd Company Overview
      • Hovione Technology Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Hovione Technology Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Papillon DPI - Product Status
        • Table Papillon DPI - Product Description
    • Iconovo AB Company Overview
      • Iconovo AB Pipeline Products & Ongoing Clinical Trials Overview
        • Table Iconovo AB Pipeline Products & Ongoing Clinical Trials Overview
        • Table ICOcap - Product Status
        • Table ICOcap - Product Description
        • Table ICOone - Product Status
        • Table ICOone - Product Description
        • Table ICOone - Oxytocin - Product Status
        • Table ICOone - Oxytocin - Product Description
        • Table ICOpre - Product Status
        • Table ICOpre - Product Description
        • Table ICOres - Product Status
        • Table ICOres - Product Description
        • Table Multi-Dose Delivery Device - Product Status
        • Table Multi-Dose Delivery Device - Product Description
        • Table Iconovo AB - Ongoing Clinical Trials Overview
        • Table ICOone - A Feasibility Study with Affilogic for the Development of Inhalable Nanofitin-based Biotherapies
        • Table ICOone - Oxytocin - A Randomized, Single-Center, Partially Single-Blind Study to Investigate the Pharmacokinetics, Safety, and Tolerability of Single and Repeated Doses of Oxytocin Administered via Inhalation or Intravenous or Intramuscular Administration in Healthy Female Participants
    • Lupin Pharmaceuticals Inc Company Overview
      • Lupin Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Lupin Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Dry Powder Inhaler 1 - Product Status
        • Table Dry Powder Inhaler 1 - Product Description
        • Table Dry Powder Inhaler 2 - Product Status
        • Table Dry Powder Inhaler 2 - Product Description
        • Table Tiotropium DPI - Product Status
        • Table Tiotropium DPI - Product Description
    • MannKind Corp Company Overview
      • MannKind Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table MannKind Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Afrezza - Pediatric Use - Product Status
        • Table Afrezza - Pediatric Use - Product Description
        • Table Afrezza Inhaler - Product Status
        • Table Afrezza Inhaler - Product Description
        • Table Treprostinil Technosphere - Product Status
        • Table Treprostinil Technosphere - Product Description
        • Table MannKind Corp - Ongoing Clinical Trials Overview
        • Table Afrezza Inhaler - INHALE-3: A 17-Week Randomized Trial and a 13-Week Extension, Evaluating the Efficacy and Safety of Inhaled Insulin (Afrezza) Combined with Insulin Degludec Versus Usual Care in Adults with Type 1 Diabetes
    • Medihale Ltd (Inactive) Company Overview
      • Medihale Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Medihale Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Toucan Multi-Dose Inhaler - Product Status
        • Table Toucan Multi-Dose Inhaler - Product Description
    • Monash University Company Overview
      • Monash University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Monash University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Aerosol Delivery System - Product Status
        • Table Aerosol Delivery System - Product Description
    • Nektar Therapeutics Company Overview
      • Nektar Therapeutics Pipeline Products & Ongoing Clinical Trials Overview
        • Table Nektar Therapeutics Pipeline Products & Ongoing Clinical Trials Overview
        • Table NKTR-061 - Product Status
        • Table NKTR-061 - Product Description
    • North Carolina State University Company Overview
      • North Carolina State University Pipeline Products & Ongoing Clinical Trials Overview
        • Table North Carolina State University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Smart Inhaler System - Product Status
        • Table Smart Inhaler System - Product Description
    • Novartis AG Company Overview
      • Novartis AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table Novartis AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table Atectura Breezhaler - Product Status
        • Table Atectura Breezhaler - Product Description
        • Table Enerzair Breezhaler - Product Status
        • Table Enerzair Breezhaler - Product Description
        • Table Next Generation Breezhaler Inhaler - Product Status
        • Table Next Generation Breezhaler Inhaler - Product Description
        • Table Novartis AG - Ongoing Clinical Trials Overview
        • Table Enerzair Breezhaler - A 24-week Prospective, Open-label, Multicenter, Single-arm, Observational Regulatory Post-Marketing Surveillance (rPMS) Study in Real-world Setting (Mandatory by Local HA Regulation) for Enerzair (QVM149 150/50/80 ìg o.d. and QVM149 150/50/160 ìg o.d. Via Breezhaler)
        • Table Enerzair Breezhaler - A Double-dummy, Double-blind, Randomized, Parallel-group, Active Controlled Study to Evaluate the Efficacy and Safety of QVM149 (Indacaterol Acetate / Glycopyrronium Bromide / Mometasone Furoate) Compared to Salmeterol Xinafoate/Fluticasone Propionate in Children From 12 Years to Less Than 18 Years of Age With Asthma.
        • Table Enerzair Breezhaler - Comparison of Enerziar and Trelegy, Single Inhaler Triple Therapy (SITT), in Asthma
        • Table Atectura Breezhaler - A 24-week Prospective, Open-label, Multicenter, Single-arm Regulatory Post-Marketing Surveillance (rPMS) Study in Real-world Setting (Mandatory by Local HA Regulation) for Atectura (QMF149 150/80 ìg o.d., QMF149 150/160 ìg o.d. and QMF149 150/320 ìg o.d. Via Breezhaler)
        • Table Atectura Breezhaler - A Double-dummy, Double-blind, Randomized, Parallel-group, Active Controlled Study to Evaluate the Efficacy and Safety of QVM149 (Indacaterol Acetate / Glycopyrronium Bromide / Mometasone Furoate) Compared to Salmeterol Xinafoate/Fluticasone Propionate in Children From 12 Years to Less Than 18 Years of Age With Asthma.
    • Ology Bioservices Inc Company Overview
      • Ology Bioservices Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Ology Bioservices Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table GelVac Intranasal Powder Vaccine Delivery System - Product Status
        • Table GelVac Intranasal Powder Vaccine Delivery System - Product Description
        • Table NanoGENT - Product Status
        • Table NanoGENT - Product Description
    • OPKO Health Inc Company Overview
      • OPKO Health Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table OPKO Health Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Inspiromatic - Product Status
        • Table Inspiromatic - Product Description
    • OtiTopic Inc Company Overview
      • OtiTopic Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table OtiTopic Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table ASPRIHALE - Product Status
        • Table ASPRIHALE - Product Description
    • Pai Life Sciences Inc Company Overview
      • Pai Life Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Pai Life Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Inhaled Delivery System - Tuberculosis - Product Status
        • Table Inhaled Delivery System - Tuberculosis - Product Description
    • Phargentis SA Company Overview
      • Phargentis SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table Phargentis SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table Glide DPI - Product Status
        • Table Glide DPI - Product Description
        • Table Indacaterol/Glycopyrronium DPI - Product Status
        • Table Indacaterol/Glycopyrronium DPI - Product Description
    • Pneuma Respiratory Inc Company Overview
      • Pneuma Respiratory Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Pneuma Respiratory Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table PNEUMAHALER - Product Status
        • Table PNEUMAHALER - Product Description
    • Pure Scientific Technologies Inc Company Overview
      • Pure Scientific Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Pure Scientific Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table PST Closed Loop Heliox Inhaler - Product Status
        • Table PST Closed Loop Heliox Inhaler - Product Description
    • PureIMS BV Company Overview
      • PureIMS BV Pipeline Products & Ongoing Clinical Trials Overview
        • Table PureIMS BV Pipeline Products & Ongoing Clinical Trials Overview
        • Table Amikacin Cyclops - Product Status
        • Table Amikacin Cyclops - Product Description
        • Table Epinephrine Cyclops - Product Status
        • Table Epinephrine Cyclops - Product Description
        • Table Levodopa Cyclops - Product Status
        • Table Levodopa Cyclops - Product Description
        • Table Tobramycin Cyclops - Product Status
        • Table Tobramycin Cyclops - Product Description
        • Table PureIMS BV - Ongoing Clinical Trials Overview
        • Table Levodopa Cyclops - Usability of Levodopa Cyclops Compared to INBRIJA During an Off Episode in Parkinson's Disease Patients
    • Quench Medical Inc Company Overview
      • Quench Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Quench Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Dry Powder Inhaler - Product Status
        • Table Dry Powder Inhaler - Product Description
    • Receptor Life Sciences Inc Company Overview
      • Receptor Life Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Receptor Life Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table RLS103 - Product Status
        • Table RLS103 - Product Description
    • Resolve Digital Health Inc Company Overview
      • Resolve Digital Health Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Resolve Digital Health Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Resolve Go MD - Product Status
        • Table Resolve Go MD - Product Description
        • Table Resolve MD - Product Status
        • Table Resolve MD - Product Description
        • Table Resolve Mini MD - Product Status
        • Table Resolve Mini MD - Product Description
    • Respira Therapeutics Inc Company Overview
      • Respira Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Respira Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table RT234 AOS DPI - Product Status
        • Table RT234 AOS DPI - Product Description
    • Respirent Pharmaceuticals Co Ltd Company Overview
      • Respirent Pharmaceuticals Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Respirent Pharmaceuticals Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Flovent Diskus - Generic Version - Product Status
        • Table Flovent Diskus - Generic Version - Product Description
    • Rhinomed Ltd Company Overview
      • Rhinomed Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Rhinomed Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Pronto Allergy Relief - Product Status
        • Table Pronto Allergy Relief - Product Description
        • Table Pronto Focus - Product Status
        • Table Pronto Focus - Product Description
        • Table Pronto Nausea Relief - Product Status
        • Table Pronto Nausea Relief - Product Description
        • Table Pronto Sleep Performance - Product Status
        • Table Pronto Sleep Performance - Product Description
    • Sandoz International GmbH Company Overview
      • Sandoz International GmbH Pipeline Products & Ongoing Clinical Trials Overview
        • Table Sandoz International GmbH Pipeline Products & Ongoing Clinical Trials Overview
        • Table Solis Multi-Dose Dry Powder Inhaler - Product Status
        • Table Solis Multi-Dose Dry Powder Inhaler - Product Description
        • Table Unit-Dose Dry Powder Inhaler - Product Status
        • Table Unit-Dose Dry Powder Inhaler - Product Description
    • Seng Vital International GmbH Company Overview
      • Seng Vital International GmbH Pipeline Products & Ongoing Clinical Trials Overview
        • Table Seng Vital International GmbH Pipeline Products & Ongoing Clinical Trials Overview
        • Table Cannamed - Product Status
        • Table Cannamed - Product Description
    • Sheffield Hallam University Company Overview
      • Sheffield Hallam University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Sheffield Hallam University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Dry Powder Inhaler - Product Status
        • Table Dry Powder Inhaler - Product Description
    • Shin Nippon Biomedical Laboratories Ltd Company Overview
      • Shin Nippon Biomedical Laboratories Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Shin Nippon Biomedical Laboratories Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table STS101 Dry Powder Delivery Device - Product Status
        • Table STS101 Dry Powder Delivery Device - Product Description
    • Sinsin Pharmaceutical Co Ltd Company Overview
      • Sinsin Pharmaceutical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Sinsin Pharmaceutical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table BVA110 - Product Status
        • Table BVA110 - Product Description
        • Table DFA001 - Product Status
        • Table DFA001 - Product Description
    • Softhale NV Company Overview
      • Softhale NV Pipeline Products & Ongoing Clinical Trials Overview
        • Table Softhale NV Pipeline Products & Ongoing Clinical Trials Overview
        • Table Softhaler - Product Status
        • Table Softhaler - Product Description
    • Spyryx Biosciences Inc (Inactive) Company Overview
      • Spyryx Biosciences Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Spyryx Biosciences Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table SPX-250 Dry Powder Inhaler - Product Status
        • Table SPX-250 Dry Powder Inhaler - Product Description
    • Syntara Ltd Company Overview
      • Syntara Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Syntara Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Orbital Dry Powder Inhaler - Product Status
        • Table Orbital Dry Powder Inhaler - Product Description
    • Teva Pharmaceutical Industries Ltd Company Overview
      • Teva Pharmaceutical Industries Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Teva Pharmaceutical Industries Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table AirDuo Digihaler - Product Status
        • Table AirDuo Digihaler - Product Description
        • Table ArmonAir Digihaler - Product Status
        • Table ArmonAir Digihaler - Product Description
        • Table Inhaler Device - Product Status
        • Table Inhaler Device - Product Description
        • Table ProAir Digihaler - Product Status
        • Table ProAir Digihaler - Product Description
        • Table Tidal Inhaler - Product Status
        • Table Tidal Inhaler - Product Description
        • Table Teva Pharmaceutical Industries Ltd - Ongoing Clinical Trials Overview
        • Table ProAir Digihaler - Utilizing Advances in Digital Inhaler Technology to Understand Heterogeneous Treatment Responses to Biologics in Severe Asthma
        • Table AirDuo Digihaler - Utilizing Advances in Digital Inhaler Technology to Understand Heterogeneous Treatment Responses to Biologics in Severe Asthma
    • Transpire Bio Inc Company Overview
      • Transpire Bio Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Transpire Bio Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table CNS Inhaler 1 - Product Status
        • Table CNS Inhaler 1 - Product Description
        • Table CNS Inhaler 2 - Product Status
        • Table CNS Inhaler 2 - Product Description
        • Table Dry Powder Inhaler (DPI) - Asthma COPD - Product Status
        • Table Dry Powder Inhaler (DPI) - Asthma COPD - Product Description
        • Table Dry Powder Inhaler (DPI) - COPD - Product Status
        • Table Dry Powder Inhaler (DPI) - COPD - Product Description
        • Table Oncology Inhaler - Product Status
        • Table Oncology Inhaler - Product Description
        • Table Soft Mist Inhaler (SMI) - COPD - Product Status
        • Table Soft Mist Inhaler (SMI) - COPD - Product Description
    • United Therapeutics Corp Company Overview
      • United Therapeutics Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table United Therapeutics Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Tyvaso DPI - Product Status
        • Table Tyvaso DPI - Product Description
        • Table United Therapeutics Corp - Ongoing Clinical Trials Overview
        • Table Tyvaso DPI - A Randomized, Double-blind, Placebo-controlled, Multinational, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis (TETON-2)
        • Table Tyvaso DPI - A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects with Idiopathic Pulmonary Fibrosis
        • Table Tyvaso DPI - An Open-label Extension Study of Inhaled Treprostinil in Subjects with Idiopathic Pulmonary Fibrosis
    • University of Kansas Company Overview
      • University of Kansas Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Kansas Pipeline Products & Ongoing Clinical Trials Overview
        • Table Dry Powder Inhaler - Product Status
        • Table Dry Powder Inhaler - Product Description
    • University of Sydney Company Overview
      • University of Sydney Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Sydney Pipeline Products & Ongoing Clinical Trials Overview
        • Table Dry Powder Inhaler - Product Status
        • Table Dry Powder Inhaler - Product Description
    • University of Texas Medical Branch at Galveston Company Overview
      • University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview
        • Table Dry Powder Drug Delivery System - Product Status
        • Table Dry Powder Drug Delivery System - Product Description
    • Uscom Ltd Company Overview
      • Uscom Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Uscom Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Spirosonic SmartSpacer - Product Status
        • Table Spirosonic SmartSpacer - Product Description
    • Vectura Group Plc Company Overview
      • Vectura Group Plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Vectura Group Plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Digitally - Connected LOMI Device - Product Status
        • Table Digitally - Connected LOMI Device - Product Description
        • Table MRX006 - Multidose Combined DPI Inhaler - Product Status
        • Table MRX006 - Multidose Combined DPI Inhaler - Product Description
        • Table SKP-2075 - Product Status
        • Table SKP-2075 - Product Description
    • Veoli Ltd Company Overview
      • Veoli Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Veoli Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Cannabis Inhaler Device - Product Status
        • Table Cannabis Inhaler Device - Product Description
    • Verona Pharma Plc Company Overview
      • Verona Pharma Plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Verona Pharma Plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table RPL554 - Dry Powder Inhaler - Product Status
        • Table RPL554 - Dry Powder Inhaler - Product Description
    • Virginia Commonwealth University Company Overview
      • Virginia Commonwealth University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Virginia Commonwealth University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Drug Delivery Device - Cystic Fibrosis - Product Status
        • Table Drug Delivery Device - Cystic Fibrosis - Product Description
        • Table Dry Powder Inhaler - Product Status
        • Table Dry Powder Inhaler - Product Description
  • Inhalers- Recent Developments
    • Jun 01, 2024: Boehringer Ingelheim's COPD and Asthma Inhalers Are Now Available for $35 a Month for Eligible Patients
    • May 24, 2024: Iconovo Publishes the Annual Report 2023
    • May 15, 2024: Cipla UPS Investment in Point-Of-Care Testing Firm Achira Labs
    • May 13, 2024: Novo Nordisk Plans Bond Sale to Fund Expansion
    • May 09, 2024: Nektar Therapeutics Reports First Quarter 2024 Financial Results
    • May 08, 2024: Teva Pharmaceutical Industries Reports Earnings Results for the First Quarter Ended March 31, 2024
    • May 06, 2024: Iconovo Receives Patent Protection for Icores in China
    • May 02, 2024: Novo Nordisk's Sales Increased by 22% in Danish kroner and by 24% at Constant Exchange Rates to DKK 65.3 billion in the First Three Months of 2024
    • May 01, 2024: MannKind Corporation to Hold 2024 First Quarter Financial Results Conference Call on May 8, 2024
    • Apr 30, 2024: 3M First-Quarter Results Driven by Strong Operational Performance; Company Initiates Full-Year 2024 Guidance Reflecting Completion of Solventum Spin
    • Apr 16, 2024: Iconovo’s partner Monash University has completed enrollment in a Phase I clinical trial of inhaled oxytocin in ICOone
    • Apr 11, 2024: Orion publishes Interim Report for January–March 2024 and Holds a Webcast on 25 April 2024
    • Apr 09, 2024: Swiss Pharma Company Novartis to Lay Off 680 Employees from Switzerland and USA Offices in Next 2-3 Years
    • Apr 03, 2024: Adherium Partners with Rimidi to Revolutionise Respiratory Clinical Management Solutions
    • Mar 18, 2024: Astrazeneca Caps Patient Out-Of-Pocket Costs at $35 per Month for its US Inhaled Respiratory Portfolio
    • Mar 15, 2024: Cipla Announces Appointment of Senior Management
    • Mar 13, 2024: 3M Names New CEO Amid PFAS Battles, Health Spinoff
    • Mar 12, 2024: 3M Announces New Leadership Appointments
    • Mar 11, 2024: Iconovo to Present Positive Data From a Feasibility Study on Nanofitins in ICOone
    • Mar 05, 2024: United Therapeutics Corporation to Present at the Leerink Partners Global Biopharma Conference 2024
    • Mar 04, 2024: Nektar Therapeutics Announces $30 Million Private Placement Financing with TCGX
    • Feb 27, 2024: MannKind Corporation Reports 2023 Fourth Quarter and Full Year Financial Results: Provides Clinical Development Update
    • Feb 20, 2024: MannKind Corporation to Hold 2023 Fourth Quarter and Full Year Financial Results Conference Call on February 27, 2024
    • Feb 08, 2024: Belhaven Biopharma Announces Groundbreaking Clinical Results for Nasdepi, the Revolutionary Nasal Dry Powder Epinephrine Product
    • Feb 07, 2024: Iconovo Signs Additional Contract with Kiox Pharma for Development of a New Inhalable Treatment for Interstitial Lung Disease
    • Feb 06, 2024: Iconovo Launches Improved Versions of Nasal Icoone Inhalers
    • Feb 01, 2024: Qualcomm Reports Q1 Fiscal 2024 Results
    • Feb 01, 2024: Iconovo Receives Order From Top-10 Pharma Company for Evaluation of Multi-Dose Inhaler
    • Jan 31, 2024: Savara to Present at Two Upcoming Healthcare Conferences
    • Jan 31, 2024: Kindeva Drug Delivery Launches New Analytical Services Global Business Unit
    • Jan 31, 2024: Kindeva Drug Delivery Launches New Analytical Services Global Business Unit
    • Jan 23, 2024: Orion Group Announces Executive Management Board
    • Jan 23, 2024: 3M Delivers Strong Fourth-Quarter Results; Improves Operational Performance and Exceeds Earnings and Cash Flow Expectations
    • Jan 16, 2024: 3M Picks Former NuVasive CEO as President of Medical Solutions
    • Jan 15, 2024: Hassan Fahmi Appointed as Managing Director of GSK Egypt
    • Jan 08, 2024: Iconovo Recruits Gary Pitcairn PhD as Senior Scientific Advisor
    • Dec 04, 2023: Adherium Commences Production and US Market Release of Advanced Teva pMDI Compatible Smartinhaler
    • Dec 04, 2023: Aptar Awarded US FDA Contract to Study Opportunities for Low Global Warming Potential Propellants for Metered Dose Inhalers
    • Nov 09, 2023: 3M Announces Leadership Changes
    • Nov 07, 2023: Tom Sweet Elected to 3M Board of Directors
    • Nov 07, 2023: Teva appoints new CEO for Teva api, its Active Pharmaceutical Ingredients Business
    • Nov 06, 2023: Acorda Therapeutics Announces Biopas Laboratories Submission to Regulatory Agencies in Six Latin American Countries for Approval of INBRIJA
    • Nov 02, 2023: Qualcomm Reports Q4 and Fiscal 2023 Results
    • Oct 31, 2023: United Therapeutics Announces First Patient Enrolled in Phase 3 TETON PPF Study of Nebulized Tyvaso in Patients with Progressive Pulmonary Fibrosis
    • Oct 27, 2023: Cipla Announces Unaudited Consolidated Financial Results for Quarter Ended September 30th, 2023
    • Oct 24, 2023: 3M Reports Third Quarter 2023 Results; Company Increases Full Year Adjusted Earnings and Cash Flow Expectations
    • Oct 19, 2023: DMK Pharmaceuticals Restructures Executive Team to Support Next Phase of Growth
    • Oct 16, 2023: Orion publishes Interim Report for January–September 2023 on Thursday 26 October 2023
    • Oct 15, 2023: Qualcomm To Layoff 1,258 Employees In Two Locations, Experts State That U.S. Efforts To Suppress China Backfired And Is Affecting Firms
    • Oct 13, 2023: Qualcomm to Lay Off 1,258 Employees in California
    • Oct 12, 2023: Qualcomm to Cut Roughly 1258 Jobs in California
    • Oct 03, 2023: Nemera reinforces commitment to sustainability with first integrated ESG report
    • Sep 28, 2023: Teva Announces Changes to Executive Management Team
    • Sep 25, 2023: Nemera Announces Commitment to sustainability
    • Sep 10, 2023: Nemera extends manufacturing capabilities in North America
    • Sep 05, 2023: MannKind Announces Participation at Upcoming Conferences
    • Aug 28, 2023: Novartis to Let Go 100 Employees in Latest Round of Layoffs
    • Aug 23, 2023: 3M Appoints Carrie Cox as Chairman of the Board of Directors of the Independent Health Care Company
    • Aug 22, 2023: Bryan Hanson Named CEO of 3M's Health Care Business Group
    • Aug 18, 2023: Qualcomm to Reportedly Cut 200 Jobs in Taiwan
    • Aug 17, 2023: Iconovo Receives Additional Development Contract From Kiox Pharma For New Inhalable Treatment Against Rare Disease
    • Aug 17, 2023: Ziccum to present at Investor Conference BioFuture 2023 in New York
    • Aug 11, 2023: Audrey Choi elected to 3M Board of Directors
    • Aug 03, 2023: Qualcomm Announces Third Quarter Fiscal 2023 Results
    • Aug 01, 2023: MannKind Announces Participation in the 2023 Wedbush PacGrow Healthcare Conference
    • Jul 31, 2023: Viatris Announces Launch of Breyna (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol, the First FDA-Approved Generic Version of Symbicort for People with Asthma and Chronic Obstructive Pulmonary Disease, in Partnership with Kindeva
    • Jul 31, 2023: MannKind to Hold 2023 Second Quarter Financial Results Conference Call on August 7, 2023
    • Jul 25, 2023: 3M Reports Second Quarter 2023 Results; Proactive Initiatives Drive Strong Quarterly Financial Results; Raises Full-Year Adjusted EPS Guidance
    • Jul 21, 2023: Teva UK Launches New Goresp Digihaler System in UK
    • Jul 20, 2023: Command Brand Announces Bobby Berk as First-Ever Director of Dorm Design
  • Appendix
    • Methodology
      • Table Glossary
    • About GlobalData
    • Contact Us
    • Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings